(Q40812418)

23 September 2017

Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance (English)

1 reference

23 September 2017

16

1 reference

23 September 2017

J Ruland

19

0 references

author name string

S Spinner

1

1 reference

23 September 2017

G Crispatzu

2

1 reference

23 September 2017

J-H Yi

3

1 reference

23 September 2017

E Munkhbaatar

4

1 reference

23 September 2017

P Mayer

5

1 reference

23 September 2017

U Höckendorf

6

1 reference

23 September 2017

N Müller

7

1 reference

23 September 2017

Z Li

8

1 reference

23 September 2017

T Schader

9

1 reference

23 September 2017

H Bendz

10

1 reference

23 September 2017

S Hartmann

11

1 reference

23 September 2017

M Yabal

12

1 reference

23 September 2017

K Pechloff

13

1 reference

23 September 2017

M Heikenwalder

14

1 reference

23 September 2017

G L Kelly

15

1 reference

23 September 2017

C Peschel

17

1 reference

23 September 2017

M-L Hansmann

18

1 reference

23 September 2017

U Keller

20

1 reference

23 September 2017

S Newrzela

21

1 reference

23 September 2017

M Herling

22

1 reference

23 September 2017

P J Jost

23

1 reference

23 September 2017

language of work or name

1 reference

8 March 2016

1 reference

23 September 2017

1 reference

23 September 2017

30

1 reference

23 September 2017

1520-1530

1 reference

23 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2016.49

23 September 2017

0 references

cites work

Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

A global map of human gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

T-cell receptor signaling in peripheral T-cell lymphoma - a review of patterns of alterations in a central growth regulatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Models for mature T-cell lymphomas--a critical appraisal of experimental systems and their contribution to current T-cell tumorigenic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

New molecular insights into peripheral T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

The BCL-2 protein family: opposing activities that mediate cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Mcl-1 is essential for germinal center formation and B cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Elevated Mcl-1 inhibits thymocyte apoptosis and alters thymic selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

The antiapoptotic protein Bcl-xL is dispensable for the development of effector and memory T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Delving deeper: MCL-1's contributions to normal and cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

BCL2A1: the underdog in the BCL2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Rapid generation of inducible mouse mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Mcl-1 is essential for the survival of plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Erratum: Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Modeling and analysis on the internal impact of a Stewart platform utilized for spacecraft docking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.49

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

21 January 2018

1 reference

12 December 2020

Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis

1 reference

12 December 2020

BCL‐2 family proteins in peripheral T‐cell lymphomas: correlation with tumour apoptosis and proliferation

1 reference

12 December 2020

A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

1 reference

12 December 2020

Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma

1 reference

12 December 2020

Influence of thymectomy, splenectomy, and gonadectomy on incidence of radiation-induced lymphoid tumors in strain C57 black mice

1 reference

12 December 2020

Mcl-1 deficiency results in peri-implantation embryonic lethality

1 reference

12 December 2020

Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach

1 reference

12 December 2020

Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma

1 reference

12 December 2020

Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q

1 reference

12 December 2020

Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers

1 reference

12 December 2020

Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly

1 reference

12 December 2020

Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice

1 reference

12 December 2020

Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2016.49

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference